| [10] |
Lee SY, Yoon BY, Kim JI, et al. Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes[J]. Immunology, 2014, 141(3): 353–361.
|
| [11] |
Kostic M, Dzopalic T, Zivanovic S, et al. IL-17 and glutamate excitotoxicity in the pathogenesis of multiple sclerosis[J]. Scand J Immunol, 2014, 79(3): 181–186.
|
| [12] |
Lee Y. The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases[J]. BMB Rep, 2013, 46(10): 479–483.
|
| [13] |
Numasaki M, Fukushi J, Ono M, et al. Interleukin-17 promotes angiogenesis and tumor growth[J]. Blood, 2003, 101(7): 2620–2627.
|
| [14] |
Tartour E, Fossiez F, Joyeux I, et al. Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice[J]. Cancer Res, 1999, 59(15): 3698–3704.
|
| [15] |
Benchetrit F, Ciree A, Vives V, et al. Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism[J]. Blood, 2002, 99(6): 2114–2121.
|
| [16] |
Martin-Orozco N, Chung Y, Chang SH, et al. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells[J]. Eur J Immunol, 2009, 39(1): 216–224.
|
| [17] |
Steiner GE, Newman ME, Paikl D, et al. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate[J]. Prostate, 2003, 56(3): 171–182.
|
| [18] |
Sfanos KS, Bruno TC, Maris CH, et al. Phenotypic analysis of prostate-infiltrating lymphocytes reveals Th17 and Treg skewing[J]. Clin Cancer Res, 2008, 14(11): 3254–3261.
|
| [19] |
Zhang B, Rong G, Wei H, et al. The prevalence of Th17 cells in patients with gastric cancer[J]. Biochem Biophys Res Commun, 2008, 374(3): 533–537.
|
| [20] |
Horlock C, Stott B, Dyson PJ, et al. The effects of trastuzumab on the CD4＋CD25＋FoxP3＋ and CD4＋IL17A＋ T-cell axis in patients with breast cancer[J]. Br J Cancer, 2009, 100(7): 1061–1067.
|
| [21] |
Yang L, Qi Y, Hu J, et al. Expression of Th17 cells in breast cancer tissue and its association with clinical parameters[J]. Cell Biochem Biophys, 2012, 62(1): 153–159.
|
| [22] |
Kryczek I, Banerjee M, Cheng P, et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments[J]. Blood, 2009, 114(6): 1141–1149.
|
| [23] |
Kryczek I, Wei S, Zou L, et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment[J]. J Immunol, 2007, 178(11): 6730–6733.
|
| [24] |
Su X, Ye J, Hsueh EC, et al. Tumor microenvironments direct the recruitment and expansion of human Th17 cells[J]. J Immunol, 2010, 184(3): 1630–1641.
|
| [25] |
Chen X, Wan J, Liu J, et al. Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients[J]. Lung Cancer, 2010, 69(3): 348–354.
|
| [1] |
Bettelli E, Korn T, Oukka M, et al. Induction and effector functions of Th17 cells[J]. Nature, 2008, 453(7198): 1051–1057.
|
| [2] |
Lan C, Huang X, Lin S, et al. High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer[J]. Cell Tissue Res, 2013, 352(2): 351–359.
|
| [3] |
Li Q, Li Q, Chen J, et al. Prevalence of Th17 and Treg cells in gastric cancer patients and its correlation with clinical parameters[J]. Oncol Rep, 2013, 30(3): 1215–1222.
|
| [4] |
Chang YH, Yu CW, Lai LC, et al. Up-regulation of interleukin-17 expression by human papillomavirus type 16 E6 in nonsmall cell lung cancer[J]. Cancer, 2010, 116(20): 4800–4809.
|
| [5] |
Zhang JP, Yan J, Xu J, et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients[J]. J Hepatol, 2009, 50(5): 980–989.
|
| [6] |
Gaffen SL. Biology of recently discovered cytokines: interleukin-17：a unique inflammatory cytokine with roles in bone biology and arthritis[J]. Arthritis Res Ther, 2004, 6(6): 240–247.
|
| [7] |
Huang SH, Frydas S, Kempuraj D, et al. Interleukin-17 and the interleukin-17 family member network[J]. Allergy Asthma Proc, 2004, 25(1): 17–21.
|
| [8] |
Kolls JK, Linden A. Interleukin-17 family members and inflammation[J]. Immunity 2004, 21(4): 467–476.
|
| [9] |
Song X, Qian Y. IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases[J]. Cell Signal, 2013, 25(12): 2335–2347.
|
| [26] |
Maruyama T, Kono K, Mizukami Y, et al. Distribution of Th17 cells and FoxP3(＋) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer[J]. Cancer Sci, 2010, 101(9): 1947–1954.
|
| [27] |
Kesselring R, Thiel A, Pries R, et al. Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development[J]. Br J Cancer, 2010, 103(8): 1245–1254.
|